2 terminated, 1 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Lowell Anthony, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Telotristat With Lutathera in Neuroendocrine Tumors Telotristat (Low-Dose), Telotristat (High-Dose) - Neuroendocrine Tumors | Phase 2 | Terminated | Lowell Anthony, MD | 1 | 2021-09-13 | 2023-06-27 |
| Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs Amino Acid Based Medical Food/Drink - Neuroendocrine Tumors, Carcinoid Tumor of GI System | Phase 2 | Completed | Lowell Anthony, MD | 10 | 2018-12-06 | 2022-11-03 |
| Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression everolimus, fosbretabulin - Neuroendocrine Tumors, Everolimus | Phase 1 | Terminated | Lowell Anthony, MD | 17 | 2017-03-06 | 2019-08-08 |
Neuroendocrine Tumors (3) · Diarrhea (1) · Serotonin Syndrome (1)
Everolimus (1) · fosbretabulin (1) · telotristat (1) · telotristat ethyl (1)
United States (3)
Lowell Anthony (1)